Fuso Pharmaceutical Industries,Ltd.

4538

JP3823600006

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
2,211 ^JPY	-0.14%		+0.55%	+16.92%

2023	Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on September 5, 2023.	CI
2023	Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 5, 2023, has closed with	CI

Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.

September 04, 2023

The Board of Directors of Fuso Pharmaceutical Industries,Ltd. has authorized a buyback plan on September 5, 2023.

Latest news about Fuso Pharmaceutical Industries,Ltd.

Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on September 5, 2023.	23-09-05	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 5, 2023, has closed with	23-09-05	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 340,000 shares, representing 3.88% for ¥735 million.	23-09-05	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	23-09-04	CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) dropped from S&P Global BMI Index	22-09-19	CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) added to S&P Global BMI Index	21-09-20	CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) dropped from S&P Global BMI Index	17-09-18	CI
Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on September 4, 2017.	17-09-04	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 4, 2017 has expired with 154,100 shares, representing 1.72% for ¥421.62 million.	17-09-04	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 200,000 shares, representing 2.24% for ¥547.2 million.	17-09-04	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	17-09-03	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	16-10-23	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 866 shares, for ¥2.3 million.	16-10-23	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on October 24, 2016 has expired.	16-10-23	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on August 29, 2016 has expired with 1,050,000 shares for ¥271.95 million.	16-08-29	CI
Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on August 29, 2016.	16-08-29	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	16-08-28	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 1,300,000 shares, representing 1.44% for ¥336.7 million.	16-08-28	CI
JA Mitsui Leasing, Ltd. cancelled the acquisition of Kyobashi Parking Lot of Fuso Pharmaceutical Industries,Ltd..	13-11-20	CI
JA Mitsui Leasing, Ltd. entered into an agreement to acquire Kyobashi Parking Lot of Fuso Pharmaceutical Industries,Ltd. for ¥4 billion.	12-11-20	CI

Chart Fuso Pharmaceutical Industries,Ltd.

Duration

Period

Chart Fuso Pharmaceutical Industries,Ltd.

More charts

Fuso Pharmaceutical Industries, Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceuticals and medical equipment for medical purposes. The Company operates in two business segments. The Pharmaceuticals segment is involved in manufacture and sale of pharmaceutical products, including injectable drugs, which mainly focus on infusion solution, dialysis fluid for artificial kidney, as well as the manufacture and sale of medical equipment and instruments. The Real Estate segment is engaged in the leasing of real estate properties.

Sector

Pharmaceuticals

Calendar

2024-05-09 - Q4 2023 Earnings Release

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
FUSO PHARMACEUTICAL INDUSTRIES,LTD.	+16.92%	119M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals